Trial
NCT05292196
A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Intervention
TQC3721 suspension for inhalation
Why stopped
Per sponsor request. Closure was not prompted by any safety or efficacy concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-20